1. THU0142 High Similarity between ex-vivo Inhibited Cytokine Profiling by Golimumab and Adalimumab as A Putative Explanation for Inferior Treatment Response To Golimumab after Adalimumab Failure in Rheumatoid Arthritis. (15th July 2016) Authors: Tweehuysen, L.; Schraa, K.; Netea, M.; van den Hoogen, F.; Joosten, L.; den Broeder, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0052 ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE. (2nd June 2020) Authors: Biavasco, R.; Molteni, R.; Stefanoni, D.; Ferrarini, M.; Ferrero, E.; Cenci, S.; Cardaci, S.; Boletta, A.; Cassina, L.; Di Stefano, G.; Dominguez Andres, J.; Doglioni, C.; Nemkov, T.; Merelli, I.; D'alessandro, A.; Montini, E.; Netea, M.; Dagna, L.; Cavalli, G. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P321: PERTURBATIONS IN STIMULUS-INDUCED CYTOKINE RESPONSES IN CHILDREN WITH BCP-ALL. (23rd June 2022) Authors: Ruechel, N.; Oldenburg, M.; Janssen, S.; Pandyra, A.; Wei, L.; Hein, D.; Jepsen, V.; Fischer, U.; Hauer, J.; Auer, F.; Beer, A.; Adams, O.; Mackenzie, C.; Jaeger, M.; Netea, M.; Borkhardt, A.; Goessling, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0025 Shift in Genetic Composition of an IL-32 Promoter Polymorphism Resuls in a Higher Cytokine Production in RA Patients. (9th June 2015) Authors: Damen, M.; Heinhuis, B.; Tweehuysen, L.; den Broeder, A.; Netea, M.; Popa, C.; Joosten, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Innate immune cell activation in symptomatic and asymptomatic atherosclerosis in humans in vivo. (September 2016) Authors: Bekkering, S.; van den Munckhof, I.; Nielen, T.; Rutten, J.; de Graaf, J.; Joosten, L.; Netea, M.; Gomes, M.; Riksen, N. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Il-18 Binding Protein: A Novel Biomarker In Obesity-Related Atherosclerosis That Modulates Lipoprotein Metabolism. (August 2019) Authors: Van Den Munckhof, I.; Horst, R. ter; Schraa, K.; Stienstra, R.; de Graaf, J.; Riksen, N.; Joosten, L.; Netea, M.; Rutten, J. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inhibition of the cholesterol synthesis pathway prevents trained innate immunity. (September 2016) Authors: Bekkering, S.; Moens, S. Bernelot; Verweij, S.; Roeters van Lennep, J.; van Tuijl, J.; Joosten, L.; Stroes, E.; Netea, M.; Riksen, N. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗